Oculis Holding AG (OCS)
7.64
+0.14
(+1.87%)
USD |
NASDAQ |
Nov 13, 16:00
7.65
+0.01
(+0.13%)
After-Hours: 19:59
Oculis Total Liabilities (Quarterly) : 28.22M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 28.22M |
| June 30, 2026 | 38.43M |
| March 31, 2026 | 58.92M |
| December 31, 2025 | 50.35M |
| September 30, 2025 | 46.81M |
| June 30, 2025 | 48.40M |
| March 31, 2025 | 46.96M |
| December 31, 2024 | 51.83M |
| September 30, 2024 | 36.01M |
| June 30, 2024 | 28.83M |
| March 31, 2024 | 21.85M |
| December 31, 2023 | 24.51M |
| Date | Value |
|---|---|
| September 30, 2023 | 25.51M |
| June 30, 2023 | 19.73M |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 7.611M |
| September 30, 2021 | 7.429M |
| June 30, 2021 | 8.873M |
| March 31, 2021 | 9.585M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Novartis AG | 79.59B |
| Roche Holding AG | -- |
| Addex Therapeutics Ltd. | 1.950M |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 278.24M |
| Shareholders Equity (Quarterly) | 250.02M |
| Debt to Equity Ratio | 0.0133 |
| Current Ratio | 10.41 |
| Net Debt Paydown Yield | -0.07% |